MARC GRASSO - 26 Jan 2022 Form 4 Insider Report for Kura Oncology, Inc. (KURA)

Role
CFO, CBO
Signature
Teresa Bair, Attorney-in-fact for Marc Grasso
Issuer symbol
KURA
Transactions as of
26 Jan 2022
Net transactions value
$0
Form type
4
Filing time
28 Jan 2022, 15:17:52 UTC
Next filing
09 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KURA Common Stock Award $0 +21,900 $0.000000 21,900 26 Jan 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KURA Option to purchase common stock Award $0 +131,000 $0.000000 131,000 26 Jan 2022 Common Stock 131,000 $14.15 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant of Restricted Stock Units (RSUs). The RSUs vest in four equal annual installments on 1/26/23, 1/26/24, 1/26/25 and 1/26/26.
F2 This option vests in 48 equal monthly installments commencing on the grant date.